what does that equate to in EPS? I see the the half year eps was down from the pcp, and from my back of the envelope calculation full year EPS will be about 9.5 cps (based on half year at 3.8cps, and a 4:6 1st/2nd half ratio) Thats equates to a current PE of approx 13.5 which would seem fully priced/expensive in the current market. I do understand though that a lot of non-recurring items were expensed during this period so 2nd half maybe a lot more in EPS terms and going forward in future years will be higher (on identifical revenues). Be interested to hear veiws as to what EPS would have been but for the one of expense items to get a clearer picture of future profitability. Have had this one on my watchlist for a while now. Still waiting to pull the trigger.
TOX Price at posting:
$1.33 Sentiment: None Disclosure: Not Held
